무슨 일이 일어났나요?
Meta chief executive Mark Zuckerberg and Anthropic founder Dario Amodei will attend a White House lunch meeting on artificial‑intelligence (AI) risk mitigation on Tuesday, September 29, 2026. The gathering will also include President Donald Trump and Speaker Mike Johnson. Two sources familiar with the plans, each confirming one executive’s attendance, disclosed the details to Politico. Both sources were granted anonymity to share non‑public information. The White House did not immediately respond to a request for comment. The meeting follows a series of recent calls from leading AI labs for a slowdown in AI development due to concerns about unmitigated critical risks.
On September 28, 2026, Politico reported that Meta CEO Mark Zuckerberg and Anthropic CEO Dario Amodei are expected to attend a White House lunch meeting focused on AI risk mitigation. The meeting is scheduled for the following day and will include President Donald Trump and Speaker Mike Johnson.
Two individuals familiar with the arrangements confirmed the attendance of each executive, and both were granted anonymity. Politico noted that the White House had not yet responded to a request for comment.
The meeting follows a broader wave of AI‑related engagements in Washington, where senior executives from leading AI labs have publicly called for a slowdown in AI development due to concerns about unmitigated risks. The gathering is part of a series of high‑level discussions aimed at addressing these concerns.
왜 중요한가요?
The attendance of two of the most influential AI leaders—Zuckerberg, who oversees Meta’s extensive AI research and deployment, and Amodei, who heads Anthropic, a company focused on safety‑oriented AI—signals heightened governmental attention to at the highest level of U.S. leadership. By bringing together the President, the Speaker of the House, and CEOs of major AI firms, the meeting could shape forthcoming regulatory frameworks, funding priorities, and international coordination on AI risk. The discussion comes amid growing bipartisan pressure to address the rapid advancement of models, potential misuse, and the need for standards that balance innovation with public safety. The outcome may influence future legislation, executive orders, or collaborative initiatives that affect how AI technologies are developed, deployed, and monitored across the United States and globally.
The presence of Zuckerberg and Amodei underscores the seriousness with which the U.S. government is treating , given their companies’ influence over large‑scale AI models and services.
Policy outcomes from this meeting could shape the next wave of AI regulation, potentially affecting everything from model licensing to data‑privacy standards and export controls.
The dialogue may also set a precedent for future collaborations between government and private AI firms, influencing how risk‑assessment frameworks are built and enforced.
대화형 메커니즘: 실제로 작동하는 방식
이 개발의 이면에 있는 기본 기술을 대화식으로 살펴보세요.
A route planner searches possible journeys using explicit rules. What does this illustrate about AI?
다음에 무엇을 볼 것인가
Watch for any statements or policy documents released after the meeting that outline new guidelines, funding allocations, or regulatory proposals. Subsequent congressional hearings or executive actions could reveal the concrete steps the administration plans to take. Additionally, monitor whether Meta or Anthropic announce internal changes—such as research pauses, safety audits, or partnership programs—in response to the discussions. Finally, observe how other AI firms and international regulators , which could indicate broader industry alignment or pushback against any emerging U.S. policy direction.
Any official statements, executive orders, or legislative proposals released in the days following the meeting that address , risk mitigation, or regulatory oversight.
Potential announcements from Meta or Anthropic regarding internal policy changes, research pauses, or new safety initiatives prompted by the White House discussion.
Reactions from other AI companies, industry groups, and international regulators that could indicate alignment or divergence from the U.S. approach.